{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:05:00Z","timestamp":1789275900671,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funding from the Universit\u00e4tsklinikum Giessen und Marburg"},{"name":"Senior professorship for Translational Oncology supported by the Anneliese Pohl Stiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumor-associated macrophages (TAMs) are key regulators of the tumor microenvironment, yet the functional specialization of TAM subsets in metastatic progression remains incompletely defined. Here, we characterized distinct TAM populations contributing to tumor-promoting mesothelial cell conversion in high-grade ovarian carcinoma using single-cell RNA sequencing of patient-derived macrophages from ascites (ascTAMs) and omental metastases (omTAMs). TAMs from these anatomical sites were clearly distinguishable by polarization states, with omTAMs exhibiting a mixed M1\u207a\/M2\u207a phenotype, in contrast to the M1\n                    <jats:sup>low<\/jats:sup>\n                    \/M2\u207a profile observed in ascTAMs. Transcriptomic analysis further revealed functional divergence of these subsets. Notably, omTAMs displayed gene signatures associated with mesothelial-to-mesenchymal transition (MMT), a critical process enabling tumor invasion across the peritoneal lining. Functionally, conditioned media from omTAMs, similar to that from classically activated M1 macrophages, induced MMT in primary mesothelial cells via TGF\u03b2 and ERK\/p38 MAPK signaling pathways. This phenotypic transition enhanced transmesothelial tumor cell invasion. Proteomic analysis identified IL-1\u03b1 as a key MMT-inducing factor secreted by pro-inflammatory macrophages. Mechanistically, IL-1\u03b1 cooperates with TGF\u03b2 by activating an autocrine TGF\u03b2\/TGFBR1 feedback loop in mesothelial cells, thereby amplifying MMT. Consistent with these findings, IL1A expression was enriched in omTAM clusters across independent patient samples and was confirmed by immunohistochemical analysis of clinical samples. From a therapeutic perspective, our study identifies new avenues to counteract the mesothelial reprogramming driven by IL-1\u03b1\u207a TAMs, potentially impeding metastatic progression.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09280-1","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:33:21Z","timestamp":1789223601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1\u03b1 secretion"],"prefix":"10.1038","volume":"17","author":[{"given":"Sophie","family":"Heidemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Finkernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mary","family":"Steitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4522-9119","authenticated-orcid":false,"given":"Julie","family":"Koennecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8532-0989","authenticated-orcid":false,"given":"Franziska","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-2020","authenticated-orcid":false,"given":"Vanessa M.","family":"Beutgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3015-5850","authenticated-orcid":false,"given":"Johannes","family":"Graumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3880-1968","authenticated-orcid":false,"given":"Julia","family":"Teply-Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-7826","authenticated-orcid":false,"given":"Thorsten","family":"Stiewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna U.","family":"Keber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-3646","authenticated-orcid":false,"given":"Niklas","family":"Gremke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"G\u00f3mez-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Pogge von Strandmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-4248","authenticated-orcid":false,"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2851-193X","authenticated-orcid":false,"given":"Silke","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"9280_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1158\/2159-8290.cd-17-0284","volume":"8","author":"OMT Pearce","year":"2018","unstructured":"Pearce OMT, Delaine-Smith RM, Maniati E, Nichols S, Wang J, B\u00f6hm S, et al. Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov. 2018;8:304\u201319. https:\/\/doi.org\/10.1158\/2159-8290.cd-17-0284.","journal-title":"Cancer Discov"},{"key":"9280_CR2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajpath.2013.04.023","volume":"183","author":"R Clark","year":"2013","unstructured":"Clark R, Krishnan V, Schoof M, Rodriguez I, Theriault B, Chekmareva M, et al. Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. Am J Pathol. 2013;183:576\u201391. https:\/\/doi.org\/10.1016\/j.ajpath.2013.04.023.","journal-title":"Am J Pathol"},{"key":"9280_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","volume":"40","author":"P Pathria","year":"2019","unstructured":"Pathria P, Louis TL, Varner JA. Targeting tumor-associated macrophages in cancer. Trends Immunol. 2019;40:310\u201327. https:\/\/doi.org\/10.1016\/j.it.2019.02.003.","journal-title":"Trends Immunol"},{"key":"9280_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","volume":"23","author":"L Cassetta","year":"2023","unstructured":"Cassetta L, Pollard JW. A timeline of tumour-associated macrophage biology. Nat Rev Cancer. 2023;23:238\u201357. https:\/\/doi.org\/10.1038\/s41568-022-00547-1.","journal-title":"Nat Rev Cancer"},{"key":"9280_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792\u2013809.e23. https:\/\/doi.org\/10.1016\/j.cell.2021.01.010.","journal-title":"Cell"},{"key":"9280_CR6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder K, Patel AA, Kong WT, Piot C, Halitzki E, Dunsmore G, et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity. 2021;54:1883\u2013.e5. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.007.","journal-title":"Immunity"},{"key":"9280_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"R-Y Ma","year":"2022","unstructured":"Ma R-Y, Black A, Qian B-Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 2022;43:546\u201363. https:\/\/doi.org\/10.1016\/j.it.2022.04.008.","journal-title":"Trends Immunol"},{"key":"9280_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112211","volume":"395","author":"SH Baek","year":"2020","unstructured":"Baek SH, Lee HW, Gangadaran P, Oh JM, Zhu L, Rajendran RL, et al. Role of M2-like macrophages in the progression of ovarian cancer. Exp Cell Res. 2020;395:112211. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112211.","journal-title":"Exp Cell Res"},{"key":"9280_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","volume":"10","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol. 2017;10:36 https:\/\/doi.org\/10.1186\/s13045-017-0408-0.","journal-title":"J Hematol Oncol"},{"key":"9280_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/labinvest.2013.69","volume":"93","author":"C-Y Liu","year":"2013","unstructured":"Liu C-Y, Xu J-Y, Shi X-Y, Huang W, Ruan T-Y, Xie P, et al. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4\/IL-10 signaling pathway. Lab Invest. 2013;93:844\u201354. https:\/\/doi.org\/10.1038\/labinvest.2013.69.","journal-title":"Lab Invest"},{"key":"9280_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63276-1","volume":"10","author":"A Macci\u00f2","year":"2020","unstructured":"Macci\u00f2 A, Gramignano G, Cherchi MC, Tanca L, Melis L, Madeddu C. Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients. Sci Rep. 2020;10:6096. https:\/\/doi.org\/10.1038\/s41598-020-63276-1.","journal-title":"Sci Rep"},{"key":"9280_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ygyno.2017.07.007","volume":"147","author":"X Yuan","year":"2017","unstructured":"Yuan X, Zhang J, Li D, Mao Y, Mo F, Du W, et al. Prognostic significance of tumor-associated macrophages in ovarian cancer: a meta-analysis. Gynecol Oncol. 2017;147:181\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.007.","journal-title":"Gynecol Oncol"},{"key":"9280_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-7-19","volume":"7","author":"M Zhang","year":"2014","unstructured":"Zhang M, He Y, Sun X, Li Q, Wang W, Zhao A, et al. A high M1\/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. J Ovarian Res. 2014;7:19. https:\/\/doi.org\/10.1186\/1757-2215-7-19.","journal-title":"J Ovarian Res"},{"key":"9280_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ijc.28335","volume":"134","author":"S Reinartz","year":"2014","unstructured":"Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, et al. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer. 2014;134:32\u201342. https:\/\/doi.org\/10.1002\/ijc.28335.","journal-title":"Int J Cancer"},{"key":"9280_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1638102","volume":"16","author":"OV Kovaleva","year":"2025","unstructured":"Kovaleva OV, Rashidova MA, Sinyov VV, Malashenko OS, Gratchev A. M1 macrophages - unexpected contribution to tumor progression. Front Immunol. 2025;16:1638102. https:\/\/doi.org\/10.3389\/fimmu.2025.1638102.","journal-title":"Front Immunol"},{"key":"9280_CR16","doi-asserted-by":"publisher","unstructured":"Oshi M, Tokumaru Y, Asaoka M, Yan L, Satyananda V, Matsuyama R, et al. M1 Macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-73624-w.","DOI":"10.1038\/s41598-020-73624-w"},{"key":"9280_CR17","doi-asserted-by":"publisher","unstructured":"Sommerfeld L, Finkernagel F, Jansen JM, Wagner U, Nist A, Stiewe T, et al. The multicellular signalling network of ovarian cancer metastases. Clin Transl Med. 2021. https:\/\/doi.org\/10.1002\/ctm2.633.","DOI":"10.1002\/ctm2.633"},{"key":"9280_CR18","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.jid.2022.04.024","volume":"142","author":"Kainulainen","year":"2022","unstructured":"Kainulainen, Takabe K, Heikkinen P, Aaltonen S, La Motte N, de C, et al. M1 Macrophages induce protumor inflammation in melanoma cells through TNFR-NF-\u03baB signaling. J Invest Dermatol. 2022;142:3041\u2013.e10. https:\/\/doi.org\/10.1016\/j.jid.2022.04.024.","journal-title":"J Invest Dermatol"},{"key":"9280_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1013506","volume":"13","author":"A Zheng","year":"2022","unstructured":"Zheng A, Wei Y, Zhao Y, Zhang T, Ma X. The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer. Front Immunol. 2022;13:1013506. https:\/\/doi.org\/10.3389\/fimmu.2022.1013506.","journal-title":"Front Immunol"},{"key":"9280_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/pp-2016-0009","volume":"1","author":"K Kawanishi","year":"2016","unstructured":"Kawanishi K. Diverse properties of the mesothelial cells in health and disease. Pleura Peritoneum. 2016;1:79\u201389. https:\/\/doi.org\/10.1515\/pp-2016-0009.","journal-title":"Pleura Peritoneum"},{"key":"9280_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biocel.2017.03.013","volume":"86","author":"J Miku\u0142a-Pietrasik","year":"2017","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Kuci\u0144ska M, Tykarski A, Ksi\u0105\u017cek K. The protective activity of mesothelial cells against peritoneal growth of gastrointestinal tumors: The role of soluble ICAM-1. Int J Biochem Cell Biol. 2017;86:26\u201331. https:\/\/doi.org\/10.1016\/j.biocel.2017.03.013.","journal-title":"Int J Biochem Cell Biol"},{"key":"9280_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.417","volume":"7","author":"J Miku\u0142a-Pietrasik","year":"2016","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Sosi\u0144ska P, Maksin K, Piotrowska-Kempisty H, Kuci\u0144ska M, et al. Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases. Cell Death Dis. 2016;7:e2565. https:\/\/doi.org\/10.1038\/cddis.2016.417.","journal-title":"Cell Death Dis"},{"key":"9280_CR23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/sj.bjc.6601635","volume":"90","author":"RM Heath","year":"2004","unstructured":"Heath RM, Jayne DG, O\u2019Leary R, Morrison EE, Guillou PJ. Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand\/Fas interaction. Br J Cancer. 2004;90:1437\u201342. https:\/\/doi.org\/10.1038\/sj.bjc.6601635.","journal-title":"Br J Cancer"},{"key":"9280_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108401","volume":"26","author":"AM Steitz","year":"2023","unstructured":"Steitz AM, Schr\u00f6der C, Knuth I, Keber CU, Sommerfeld L, Finkernagel F, et al. TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion. iScience. 2023;26:108401. https:\/\/doi.org\/10.1016\/j.isci.2023.108401.","journal-title":"iScience"},{"key":"9280_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fphar.2015.00113","volume":"6","author":"SE Mutsaers","year":"2015","unstructured":"Mutsaers SE, Birnie K, Lansley S, Herrick SE, Lim C-B, Pr\u00eale CM. Mesothelial cells in tissue repair and fibrosis. Front Pharmacol. 2015;6:113 https:\/\/doi.org\/10.3389\/fphar.2015.00113.","journal-title":"Front Pharmacol"},{"key":"9280_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/path.4889","volume":"242","author":"A Rynne-Vidal","year":"2017","unstructured":"Rynne-Vidal A, Au-Yeung CL, Jim\u00e9nez-Heffernan JA, P\u00e9rez-Lozano ML, Cremades-Jimeno L, B\u00e1rcena C, et al. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. J Pathol. 2017;242:140\u201351. https:\/\/doi.org\/10.1002\/path.4889.","journal-title":"J Pathol"},{"key":"9280_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/path.4281","volume":"231","author":"P Sandoval","year":"2013","unstructured":"Sandoval P, Jim\u00e9nez-Heffernan JA, Rynne-Vidal \u00c1, P\u00e9rez-Lozano ML, Gilsanz \u00c1, Ruiz-Carpio V, et al. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. J Pathol. 2013;231:517\u201331. https:\/\/doi.org\/10.1002\/path.4281.","journal-title":"J Pathol"},{"key":"9280_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/2159-8290.CD-11-0117","volume":"1","author":"HA Kenny","year":"2011","unstructured":"Kenny HA, Nieman KM, Mitra AK, Lengyel E. The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer. Cancer Discov. 2011;1:100\u20132. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0117.","journal-title":"Cancer Discov"},{"key":"9280_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10120-017-0726-5","volume":"21","author":"H Saito","year":"2018","unstructured":"Saito H, Fushida S, Harada S, Miyashita T, Oyama K, Yamaguchi T, et al. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast. Gastric Cancer. 2018;21:55\u201367. https:\/\/doi.org\/10.1007\/s10120-017-0726-5.","journal-title":"Gastric Cancer"},{"key":"9280_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113613","volume":"43","author":"A Yonemura","year":"2024","unstructured":"Yonemura A, Semba T, Zhang J, Fan Y, Yasuda-Yoshihara N, Wang H, et al. Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment. Cell Rep. 2024;43:113613. https:\/\/doi.org\/10.1016\/j.celrep.2023.113613.","journal-title":"Cell Rep"},{"key":"9280_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ki.2013.217","volume":"84","author":"R Catar","year":"2013","unstructured":"Catar R, Witowski J, Wagner P, Annett Schramm I, Kawka E, Philippe A, et al. The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation. Kidney Int. 2013;84:1119\u201328. https:\/\/doi.org\/10.1038\/ki.2013.217.","journal-title":"Kidney Int"},{"key":"9280_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1242\/dmm.001321","volume":"1","author":"R Strippoli","year":"2008","unstructured":"Strippoli R, Benedicto I, P\u00e9rez Lozano ML, Cerezo A, L\u00f3pez-Cabrera M, Del Pozo MA. Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK\/NF-kappaB\/Snail1 pathway. Dis Model Mech. 2008;1:264\u201374. https:\/\/doi.org\/10.1242\/dmm.001321.","journal-title":"Dis Model Mech"},{"key":"9280_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2003","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Lara-Pezzi E, Selgas R, Ram\u00edrez-Huesca M, Dom\u00ednguez-Jim\u00e9nez C, Jim\u00e9nez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348:403\u201313. https:\/\/doi.org\/10.1056\/NEJMoa020809.","journal-title":"N Engl J Med"},{"key":"9280_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1074\/mcp.RA117.000400","volume":"17","author":"T Worzfeld","year":"2018","unstructured":"Worzfeld T, Finkernagel F, Reinartz S, Konzer A, Adhikary T, Nist A, et al. Proteotranscriptomics reveal signaling networks in the ovarian cancer microenvironment. Mol Cell Proteom. 2018;17:270\u201389. https:\/\/doi.org\/10.1074\/mcp.RA117.000400.","journal-title":"Mol Cell Proteom"},{"key":"9280_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1604","volume":"14","author":"F Neuhaus","year":"2024","unstructured":"Neuhaus F, Lieber S, Shinkevich V, Steitz AM, Raifer H, Roth K, et al. Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells. Clin Transl Med. 2024;14:e1604. https:\/\/doi.org\/10.1002\/ctm2.1604.","journal-title":"Clin Transl Med"},{"key":"9280_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872155","volume":"13","author":"D Boraschi","year":"2022","unstructured":"Boraschi D. What Is IL-1 for? The functions of interleukin-1 across evolution. Front Immunol. 2022;13:872155. https:\/\/doi.org\/10.3389\/fimmu.2022.872155.","journal-title":"Front Immunol"},{"key":"9280_CR37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/s0272-6386(01)80132-3","volume":"37","author":"JM Fan","year":"2001","unstructured":"Fan JM, Huang XR, Ng YY, Nikolic-Paterson DJ, Mu W, Atkins RC, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis. 2001;37:820\u201331. https:\/\/doi.org\/10.1016\/s0272-6386(01)80132-3.","journal-title":"Am J Kidney Dis"},{"key":"9280_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0014-4827(85)90197-1","volume":"160","author":"MJ Niedbala","year":"1985","unstructured":"Niedbala MJ, Crickard K, Bernacki RJ. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. Vitr Model Syst Stud tumor Cell Adhes Invasion Exp Cell Res. 1985;160:499\u2013513. https:\/\/doi.org\/10.1016\/0014-4827(85)90197-1.","journal-title":"Vitr Model Syst Stud tumor Cell Adhes Invasion Exp Cell Res"},{"key":"9280_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.molmed.2025.03.014","volume":"31","author":"R Sheng","year":"2025","unstructured":"Sheng R, Yin Y, Wang X. Mesothelial and immune cells interplay in the tumor microenvironment. Trends Mol Med. 2025;31:895\u2013908. https:\/\/doi.org\/10.1016\/j.molmed.2025.03.014.","journal-title":"Trends Mol Med"},{"key":"9280_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102763","volume":"20","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio MC, et al. Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2021;20:102763. https:\/\/doi.org\/10.1016\/j.autrev.2021.102763.","journal-title":"Autoimmun Rev"},{"key":"9280_CR41","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41416-024-02677-9","volume":"130","author":"J Kment","year":"2024","unstructured":"Kment J, Newsted D, Young S, Vermeulen MC, Laight BJ, Greer PA, et al. Blockade of TGF-\u03b2 and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. Br J Cancer. 2024;130:2003\u201315. https:\/\/doi.org\/10.1038\/s41416-024-02677-9.","journal-title":"Br J Cancer"},{"key":"9280_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9:176 https:\/\/doi.org\/10.1038\/s41392-024-01868-3.","journal-title":"Signal Transduct Target Ther"},{"key":"9280_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ygyno.2014.08.025","volume":"135","author":"B Trabert","year":"2014","unstructured":"Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, et al. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol. 2014;135:297\u2013304. https:\/\/doi.org\/10.1016\/j.ygyno.2014.08.025.","journal-title":"Gynecol Oncol"},{"key":"9280_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1653017","volume":"15","author":"S St\u0119pie\u0144","year":"2025","unstructured":"St\u0119pie\u0144 S, Smycz-Kuba\u0144ska M, Morawiec M-L, Seweryn KR, Mielczarek-Palacz A. Interleukin 1 family dysregulation in serum and peritoneal fluid of ovarian cancer patients - potential clinical implications. Front Oncol. 2025;15:1653017. https:\/\/doi.org\/10.3389\/fonc.2025.1653017.","journal-title":"Front Oncol"},{"key":"9280_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(21)02175-9","volume":"399","author":"DM Gershenson","year":"2022","unstructured":"Gershenson DM, Miller A, Brady WE, Paul J, Carty K, Rodgers W, et al. Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281\/LOGS): an international, randomised, open-label, multicentre, phase 2\/3 trial. Lancet. 2022;399:541\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(21)02175-9.","journal-title":"Lancet"},{"key":"9280_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jss.2018.02.012","volume":"227","author":"EJ Macarak","year":"2018","unstructured":"Macarak EJ, Lotto CE, Koganti D, Jin X, Wermuth PJ, Olsson A-K, et al. Trametinib prevents mesothelial-mesenchymal transition and ameliorates abdominal adhesion formation. J Surg Res. 2018;227:198\u2013210. https:\/\/doi.org\/10.1016\/j.jss.2018.02.012.","journal-title":"J Surg Res"},{"key":"9280_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104172","volume":"93","author":"IN Khan","year":"2026","unstructured":"Khan IN, Awasthi K, Wang Z, Irfan NM, Saepoo J, Whittier JN, et al. C-terminal interleukin 1 alpha (IL-1\u03b1) overexpression drives EMT and a vulnerability to ferroptosis in HNSCC. Redox Biol. 2026;93:104172. https:\/\/doi.org\/10.1016\/j.redox.2026.104172.","journal-title":"Redox Biol"},{"key":"9280_CR48","doi-asserted-by":"publisher","unstructured":"Krishnamohan M, Kaplanov I, Maudi-Boker S, Yousef M, Machluf-Katz N, Cohen I, et al. Tumor cell-associated IL-1\u03b1 affects breast cancer progression and metastasis in mice through manipulation of the tumor immune microenvironment. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25073950.","DOI":"10.3390\/ijms25073950"},{"key":"9280_CR49","doi-asserted-by":"publisher","first-page":"24272","DOI":"10.18632\/oncotarget.24917","volume":"9","author":"RB Bednarczyk","year":"2018","unstructured":"Bednarczyk RB, Tuli NY, Hanly EK, Rahoma GB, Maniyar R, Mittelman A, et al. Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer. Oncotarget. 2018;9:24272\u201382. https:\/\/doi.org\/10.18632\/oncotarget.24917.","journal-title":"Oncotarget"},{"key":"9280_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302857","volume":"10","author":"M Hao","year":"2023","unstructured":"Hao M, Huang B, Wu R, Peng Z, Luo KQ. The interaction between macrophages and triple-negative breast cancer cells induces ROS-mediated interleukin 1\u03b1 expression to enhance tumorigenesis and metastasis. Adv Sci (Weinh). 2023;10:e2302857. https:\/\/doi.org\/10.1002\/advs.202302857.","journal-title":"Adv Sci (Weinh)"},{"key":"9280_CR51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1470-2045(17)30006-2","volume":"18","author":"T Hickish","year":"2017","unstructured":"Hickish T, Andre T, Wyrwicz L, Saunders M, Sarosiek T, Kocsis J, et al. MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 2017;18:192\u2013201. https:\/\/doi.org\/10.1016\/S1470-2045(17)30006-2.","journal-title":"Lancet Oncol"},{"key":"9280_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-30224-w","volume":"15","author":"A Dyer","year":"2025","unstructured":"Dyer A, Dudley R, Ahuja S, Alsinet C, Poudel P, Bowyer G, et al. Characterisation of human in vitro tumour-associated macrophage models to define translational relevance. Sci Rep. 2025;15:45648. https:\/\/doi.org\/10.1038\/s41598-025-30224-w.","journal-title":"Sci Rep"},{"key":"9280_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8419","volume":"6","author":"TA Ince","year":"2015","unstructured":"Ince TA, Sousa AD, Jones MA, Harrell JC, Agoston ES, Krohn M, et al. Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours. Nat Commun. 2015;6:7419. https:\/\/doi.org\/10.1038\/ncomms8419.","journal-title":"Nat Commun"},{"key":"9280_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/1878-0261.12396","volume":"13","author":"S Reinartz","year":"2019","unstructured":"Reinartz S, Lieber S, Pesek J, Brandt DT, Asafova A, Finkernagel F, et al. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment. Mol Oncol. 2019;13:185\u2013201. https:\/\/doi.org\/10.1002\/1878-0261.12396.","journal-title":"Mol Oncol"},{"key":"9280_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2438-8","volume":"11","author":"AM Steitz","year":"2020","unstructured":"Steitz AM, Steffes A, Finkernagel F, Unger A, Sommerfeld L, Jansen JM, et al. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. Cell Death Dis. 2020;11:249. https:\/\/doi.org\/10.1038\/s41419-020-2438-8.","journal-title":"Cell Death Dis"},{"key":"9280_CR56","first-page":"2875","volume":"29","author":"RL Giuntoli","year":"2009","unstructured":"Giuntoli RL, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, et al. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res. 2009;29:2875\u201384.","journal-title":"Anticancer Res"},{"key":"9280_CR57","doi-asserted-by":"publisher","unstructured":"Sommerfeld L, Knuth I, Finkernagel F, Pesek J, Nockher WA, Jansen JM, et al. Prostacyclin released by cancer-associated fibroblasts promotes immunosuppressive and pro-metastatic macrophage polarization in the ovarian cancer microenvironment. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14246154.","DOI":"10.3390\/cancers14246154"},{"key":"9280_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"key":"9280_CR59","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gkae1071","volume":"53","author":"SC Dyer","year":"2025","unstructured":"Dyer SC, Austine-Orimoloye O, Azov AG, Barba M, Barnes I, Barrera-Enriquez VP, et al. Ensembl 2025. Nucleic Acids Res. 2025;53:D948\u2013D957. https:\/\/doi.org\/10.1093\/nar\/gkae1071.","journal-title":"Nucleic Acids Res"},{"key":"9280_CR60","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 2017;27:491\u20139. https:\/\/doi.org\/10.1101\/gr.209601.116.","journal-title":"Genome Res"},{"key":"9280_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","journal-title":"Bioinformatics"},{"key":"9280_CR62","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"key":"9280_CR63","doi-asserted-by":"publisher","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"2008","author":"VD Blondel","year":"2008","unstructured":"Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J Stat Mech. 2008;2008:P10008 https:\/\/doi.org\/10.1088\/1742-5468\/2008\/10\/P10008.","journal-title":"J Stat Mech"},{"key":"9280_CR64","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9:e95192 https:\/\/doi.org\/10.1371\/journal.pone.0095192.","journal-title":"PLoS One"},{"key":"9280_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J, Bj\u00f6rkesten J, Assarsson E, Henriksson S, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteom. 2021;20:100168. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168.","journal-title":"Mol Cell Proteom"},{"key":"9280_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1691010","volume":"13","author":"Pedro","year":"2025","unstructured":"Pedro, de M\u00c1, Pulido M, Marchena AM, \u00c1lvarez V, Gonz\u00e1lez-Nu\u00f1o FM, et al. Menstrual blood-derived mesenchymal stromal cell secretome modulates macrophage polarization in a preconditioning-dependent manner. Front Cell Dev Biol. 2025;13:1691010. https:\/\/doi.org\/10.3389\/fcell.2025.1691010.","journal-title":"Front Cell Dev Biol"},{"key":"9280_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2019","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2019;17:41\u20134. https:\/\/doi.org\/10.1038\/s41592-019-0638-x.","journal-title":"Nat Methods"},{"key":"9280_CR68","unstructured":"Bhagwat A, Cotton R, Graumann J. autonomics: Unified Statistical Modeling of Omics Data. doi:10.18129\/B9.bioc.autonomics. R package version 1.20.0, 2026 https:\/\/bioconductor.org\/packages\/autonomics."},{"key":"9280_CR69","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47 https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"9280_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz0274","author":"M Uhl\u00e9n","year":"2019","unstructured":"Uhl\u00e9n M, Karlsson MJ, Hober A, Svensson A-S, Scheffel J, Kotol D, et al. The human secretome. Sci Signal. 2019. https:\/\/doi.org\/10.1126\/scisignal.aaz0274.","journal-title":"Sci Signal"},{"key":"9280_CR71","doi-asserted-by":"publisher","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","volume":"49","author":"The Gene Ontology Resource","year":"2021","unstructured":"The Gene Ontology ResourceEnriching a GOld mine. Nucleic Acids Res. 2021;49:D325\u201334. https:\/\/doi.org\/10.1093\/nar\/gkaa1113.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09280-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09280-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09280-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:14:35Z","timestamp":1789272875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09280-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9280"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09280-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The collection and analysis of human specimens used in this study were approved by the ethics committee at Marburg University (reference number 205\/10, Amendment 1-5). All patients and donors were informed and provided consent to participate according to the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"794"}}